New VTE Guidelines Released
The American College of Chest Physicians (CHEST) issued some new guidelines for the treatment of venous thromboembolism (VTE).
New Indication for Pradaxa
RIDGEFIELD, Conn., November 23, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Pradaxa® (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip replacement surgery.
Spreading the Word About Thrombosis
After fracturing her ankle and getting a cast, South African athlete Marie-Victoire Cumming began feeling extreme discomfort in her leg. What she didn't know was that she had a potentially life-threatening condition called deep vein thrombosis.
FDA Approves Anti-Clotting Drug Savaysa
The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
Patients Have Power to Lower Post-Surgery Clot Risk
The risk for blood clots may go up after surgery, but patients can take steps to lower that risk.
Common Medicines May Increase Blood Clot Risk
When dealing with a headache or other pain, many people reach for over-the-counter pain relievers like naproxen or ibuprofen. But these types of medication, known as non-steroidal anti-inflammatory drugs (NSAIDS), could come with an increased risk of blood clots.
Aspirin Effective for Clot Prevention in Certain Patients
New research suggests that aspirin may be a safe alternative for those who have to stop taking anti-blood-clotting medicines.
HPV Shot Not Linked to Blood Clots
One of the few vaccines that can actually protect against cancer is the human papillomavirus (HPV) vaccine, which prevents four strains of HPV. But some parents have expressed concerns about the safety of the HPV vaccine.
Clot-Busting Therapy for Pulmonary Embolism Lowered Death Risk
Pulmonary embolism is a condition that can strike suddenly, sometimes with deadly consequences. New research on treatments for the condition could lead to better outcomes and understanding of risk factors.
FDA Approves Pradaxa for Clotting Disorders
US regulators have approved a medication to treat and reduce two dangerous clotting disorders.